4763 — Jinan Acetate Chemical Co Balance Sheet
0.000.00%
- TWD80.81bn
- TWD66.60bn
- TWD15.71bn
- 72
- 59
- 90
- 88
Annual balance sheet for Jinan Acetate Chemical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 836 | 815 | 2,007 | 8,566 | 14,396 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 701 | 480 | 280 | 413 | 999 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,913 | 2,146 | 3,406 | 9,856 | 16,804 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,034 | 1,421 | 1,908 | 2,039 | 4,062 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 3,109 | 3,635 | 5,412 | 11,999 | 20,980 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 916 | 1,372 | 1,705 | 1,677 | 4,581 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,620 | 2,118 | 1,907 | 1,800 | 4,758 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 1,489 | 1,517 | 3,505 | 10,199 | 16,222 |
Total Liabilities & Shareholders' Equity | 3,109 | 3,635 | 5,412 | 11,999 | 20,980 |
Total Common Shares Outstanding |